CLINICAL_TRIALS
withdrawal
· 2012-06-18
Clinical Trial Update: Prazosin as an Antimanic Agent in Severe Mania or Mixed States [NA]
Summary
A clinical trial evaluating prazosin as an antimanic agent in bipolar mania or mixed states has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mclean Hospital | Conditions: Bipolar, Mania, Bipolar, Mixed State | NA | Status: WITHDRAWN